Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer

被引:3
|
作者
Neoptolemos, John P. [1 ]
Ghaneh, Paula [2 ]
Hackert, Thilo [1 ]
机构
[1] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[2] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Clin Canc Med, Liverpool, Merseyside, England
关键词
GEMCITABINE; THERAPY;
D O I
10.21037/hbsn-21-131
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:714 / 716
页数:3
相关论文
共 50 条
  • [1] Treatment of Borderline Resectable Pancreatic Cancer
    Cooper, Amanda B.
    Tzeng, Ching-Wei D.
    Katz, Matthew H. G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (03) : 293 - 310
  • [2] Treatment of Borderline Resectable Pancreatic Cancer
    Amanda B. Cooper
    Ching-Wei D. Tzeng
    Matthew H. G. Katz
    Current Treatment Options in Oncology, 2013, 14 : 293 - 310
  • [3] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Janssen, Quisette P.
    O'Reilly, Eileen M.
    Van Eijck, Casper H. J.
    Groot Koerkamp, Bas
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    CHIRURG, 2020, 91 (05): : 391 - 395
  • [6] Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy
    Douglas B. Evans
    Beth A. Erickson
    Paul Ritch
    Annals of Surgical Oncology, 2010, 17 : 2803 - 2805
  • [7] Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy
    Evans, Douglas B.
    Erickson, Beth A.
    Ritch, Paul
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (11) : 2803 - 2805
  • [8] Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
    Heinemann, V.
    Haas, M.
    Boeck, S.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2484 - 2492
  • [9] The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
    Tatsuma Sakaguchi
    Sohei Satoi
    Tomohisa Yamamoto
    So Yamaki
    Mitsugu Sekimoto
    Surgery Today, 2020, 50 : 335 - 343
  • [10] The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
    Sakaguchi, Tatsuma
    Satoi, Sohei
    Yamamoto, Tomohisa
    Yamaki, So
    Sekimoto, Mitsugu
    SURGERY TODAY, 2020, 50 (04) : 335 - 343